Asv dise in neurotoxic snake bite
Reading File
Finding Sources
Finding Sources
Searching PubMed
antivenom dosing neurotoxic snakebite
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Searching the Web
ASV dose neurotoxic snakebite India WHO guidelines vials
Finding Sources
I now have comprehensive information from both textbooks and Indian/WHO guidelines. Here is a detailed, structured answer:
ASV Dose in Neurotoxic Snakebite
Which Snakes Cause Neurotoxic Envenomation?
Neurotoxic envenomation is caused primarily by elapids - cobras (Naja spp.), kraits (Bungarus spp.), king cobra, sea snakes, mambas, Australian elapids (tiger snake, taipan, death adder), and coral snakes. Venom acts at the neuromuscular junction causing descending symmetric flaccid paralysis.
Indications for ASV in Neurotoxic Snakebite
ASV is indicated at the first sign of neurotoxicity, including:
- Ptosis (drooping eyelid - earliest sign)
- Cranial nerve dysfunction (diplopia, dysarthria, dysphagia)
- Progressive peripheral muscle weakness
- Diaphragmatic involvement / respiratory insufficiency
- Loss of gag reflex
Do not wait for full-blown paralysis - antivenom is effective only in reversing active/circulating venom, not established paralysis.
ASV Dosing Regimen (India/NHM/WHO Guidelines)
Initial Dose
| Severity | Dose |
|---|---|
| Mild neurotoxic envenomation (systemic symptoms >3 h after bite) | 8-10 vials IV |
| Severe neurotoxic envenomation (systemic symptoms <3 h after bite) | 8-10 vials IV |
- Each vial = 10 mL of reconstituted polyvalent ASV
- Children receive the same dose as adults (venom load is the same regardless of body weight)
Route and Administration
- IV only - dilute 1:10 in normal saline (lower dilution in small children or cardiac-compromised patients)
- Start infusion slowly, clinician at bedside ready to treat anaphylaxis
- Gradually increase rate - give entire dose over 20-30 minutes (or longer for high-volume antivenom)
- Avoid IM route (slow absorption, risk with coagulopathy)
Repeat Dose
- Reassess after 1-2 hours of initial dose
- If neurotoxic symptoms have worsened or not improved: give a second dose of 10 vials (same as initial dose)
- After the second dose, discontinue ASV (regardless of ongoing paralysis)
Maximum Dose
- 20 vials maximum for neurotoxic envenomation (NHM/WHO Indian guidelines)
- Rationale: 20 vials is assumed to neutralize all circulating venom
- Exception: King cobra or Australian elapids (massive venom load) - may require 50+ vials
Once Maximum Dose is Given
Once the patient has received 20 vials and still has respiratory failure - stop ASV and provide mechanical ventilation. Recovery may take days to weeks depending on:
- Pre-synaptic toxins (e.g., kraits, taipans) - very difficult to reverse once established; ventilatory support is the mainstay
- Post-synaptic toxins (e.g., cobras) - more amenable to antivenom reversal + anticholinesterases
Neurotoxic Envenomation - Key Dosing Comparison
| Guideline | Initial Dose | Repeat Dose | Max Dose |
|---|---|---|---|
| Indian NHM / SCTIMST | 8-10 vials | 10 vials at 1-2 h if no improvement | 20 vials |
| WHO (Asia/Africa) | 8-10 vials | Based on clinical response | 20 vials for neurotoxic |
| Coral snake (US) | 3-5 vials (Anti-venin M. fulvius) | Additional doses if symptoms appear | Per clinical judgment |
| King cobra / Australian | 50+ vials | Per manufacturer insert | N/A (massive venom) |
Adjunct: Neostigmine for Post-Synaptic Neurotoxicity
For cobra bites (post-synaptic neurotoxin at nicotinic ACh receptor), anticholinesterases can help:
- Neostigmine 0.5-2.5 mg (adult) IV/IM + atropine 0.6 mg IV to prevent muscarinic side effects
- Test with a single dose - if improvement in ptosis or respiration within 30-60 minutes, continue
- Does not work for pre-synaptic toxins (kraits, taipans, death adders)
Adverse Reactions to ASV
- Early (anaphylaxis): Urticaria, tachycardia, bronchospasm, hypotension - treat with adrenaline 0.5 mg IM (child: 0.01 mg/kg)
- Late (serum sickness): 5-10 days after; treat with steroids
- Skin testing before ASV is NOT recommended (neither sensitive nor specific)
- Pre-treatment with low-dose SC adrenaline 0.25 mg (1:1000) reduces anaphylaxis risk (evidence from Sri Lanka)
- Have adrenaline, antihistamines, and resuscitation equipment at the bedside
Key Points to Remember
- Antivenom reverses circulating venom only - once paralysis is established (especially pre-synaptic), ASV adds little benefit
- Ventilatory support is the cornerstone of management once respiratory failure occurs
- The dose is the same in children and adults
- Do not use IM route - IV is mandatory
- Recurrence of neurotoxic envenomation after cobra bite has been described - monitor closely
- Indian polyvalent ASV is an F(ab')2 product with a half-life >90 hours - prophylactic re-dosing to prevent recurrence is not needed
Sources: Harrison's Principles of Internal Medicine 22E (2025), Tintinalli's Emergency Medicine, NHM India Snakebite Guidelines, SCTIMST Indian Protocol
This is a shared conversation. Sign in to Orris to start your own chat.